Altre lingue Harbin Gloria Pharmaceuticals Co., Ltd

Azioni

002437

CNE100000QG8

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 05/07/2024			Variaz. 5gg	Var. 1 gen.
1,93 ^CNY	+2,12%		+13,53%	-23,11%

04/07	L'utile di Harbin Gloria Pharmaceuticals nel primo semestre aumenterà fino al 360%	MT
26/04	HARBIN GLORIA PHARMACEUTICALS Co., LTD riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Harbin Gloria Pharmaceuticals' H1 Profit to Soar Up to 360%	04/07
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	12/04
HARBIN GLORIA PHARMACEUTICALS Co., LTD completed the acquisition of additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd.	28/10/23
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
HARBIN GLORIA PHARMACEUTICALS Co., LTD agreed to acquire additional 10% stake in Harbin Dandelion Pharmaceuticals Co., Ltd. from Harbin Hanjun Investment Co., Ltd. for CNY 35 million.	17/10/23
HARBIN GLORIA PHARMACEUTICALS Co., LTD(XSEC:002437) added to S&P Global BMI Index	18/09/23
HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	28/07/23
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan	29/06/23
Harbin Gloria Pharma Offloads Entire 42% Stake in Biotech Unit for 240 Million Yuan	29/06/23
Qingdao Pusheng Puli Enterprise Management Center (Limited Partnership) agreed to acquire 42.1204% stake in Guangzhou Gloria Biosciences Co., Ltd. from HARBIN GLORIA PHARMACEUTICALS Co., LTD for CNY240 million.	29/06/23
HARBIN GLORIA PHARMACEUTICALS Co., LTD announced that it expects to receive CNY 300 million in funding	15/05/23
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23/04/23
Consortium of buyers completed the acquisition of a 32.13% stake in Harbin Gloria Pharmaceuticals Co., Ltd from Harbin Gloria Group Co., Ltd.	07/04/23
Harbin Gloria Pharma Swings to Loss in 2022 on Asset Impairment	11/01/23
Harbin Gloria Pharmaceuticals Co., Ltd Announces Executive Appointments	21/12/22
Harbin Gloria Pharmaceuticals Co., Ltd Approves Executive Appointments	14/11/22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Harbin Gloria Pharmaceuticals Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	28/08/22
Guangzhou Gloria Biosciences Co., Ltd. announced that it expects to receive CNY 200 million in funding from Harbin Gloria Pharmaceuticals Co., Ltd	13/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Harbin Gloria Pharmaceuticals Co., Ltd

Azioni

002437

CNE100000QG8

Altre lingue

Filtri